The use of implantable cardioverter defibrillators in Iceland: a retrospective population based study
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Arnar, David O
MetadataShow full item record
CitationBMC Cardiovasc Disord 2006, 6:22
AbstractBACKGROUND: Indications for implantable cardioverter defibrillator (ICD) implantation have expanded considerably in recent years, resulting in steadily growing numbers of ICD recipients worldwide. The aim of this study was to review the overall experience with ICDs in Iceland. METHODS: This was a retrospective single centre study set at the University Hospital in Iceland. Data on all ICD implantations in Iceland from the first implantation in 1992 till the end of 2002 was reviewed. RESULTS: Sixty-two patients (71% male) received an ICD during this period. There was an increase in the number of implants by year and the number of new implants in 2001 and 2002 amounted to 56 and 38 per million, respectively. The mean age at implantation was 58 (+/-14) years. Forty patients (65%) had coronary artery disease. The most common indications for ICD implantation were cardiac arrest, 32 (52%) and another 26 (42%) had experienced ventricular tachycardia without cardiac arrest. The most common adverse event was inappropriate shocks. Twenty-eight patients (45%) received therapy from their ICDs, with the majority receiving appropriate therapy. Of the thirteen patients deceased before or during the study period, no case of sudden arrhythmic death was observed. CONCLUSION: This study shows that the experience with ICDs in Iceland is in most respects similar to other Western countries.
DescriptionTo access full text version of this article. Please click on the hyperlink "View/open" at the bottom of this page
- Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
- Authors: Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B
- Issue date: 2012
- Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society.
- Authors: Silka MJ, Kron J, Dunnigan A, Dick M 2nd
- Issue date: 1993 Mar
- [The implantable cardioverter-defibrillator: the Portuguese experience].
- Authors: Adragão P, Neves J, Sousa J, Fançoni J, da Silva N, Antunes E, Elvas L, Bernardo J
- Issue date: 1997 Apr
- Incidence and causes of inappropriate detection and therapy by implantable defibrillators of cardioversion in patients with ventricular tachyarrhythmia.
- Authors: Chen RH, Chen KP, Wang FZ, Hua W, Chen X, Zhang S
- Issue date: 2006 Apr 5
- Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses.
- Authors: Pires LA, Lehmann MH, Steinman RT, Baga JJ, Schuger CD
- Issue date: 1999 Jan